| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 02/05/2004 | WO2004010974A2 Gelatin capsule exhibiting reduced cross-linking |
| 02/05/2004 | WO2004010973A2 Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage |
| 02/05/2004 | WO2004010972A2 Pellicle-resistant gelatin capsule |
| 02/05/2004 | WO2004010950A2 Aryl substituted hydantoin compounds and their use as sodium channel blockers |
| 02/05/2004 | WO2003084938A3 Pyrimidone derivatives useful for the treatment of inflammatin and immunological diseases |
| 02/05/2004 | WO2003075857A3 Amino-methyl substituted tetracycline compounds |
| 02/05/2004 | WO2003074654A3 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina) |
| 02/05/2004 | WO2003042397A3 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 02/05/2004 | WO2002061046A3 Novel nucleic acid and polypeptide molecules |
| 02/05/2004 | US20040024208 Cyclic protein tyrosine kinase inhibitors |
| 02/05/2004 | US20040024061 Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and the alkanoyl l-carnitines with taurine chloride and glycine chloride |
| 02/05/2004 | US20040024000 Dihydropyrimidine derivatives as cysteine protease inhibitors |
| 02/05/2004 | US20040023992 Antiinflammatory agents |
| 02/05/2004 | US20040023973 Novel compound having an excellent AMPA receptor inhibitory action and/or kainate inhibitory action. A compound represented by the following formula, a salt thereof or hydrates thereof. |
| 02/05/2004 | US20040023963 Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases |
| 02/05/2004 | US20040023883 IGF-I and insulin variants are provided that selectively bind to IGFBP-1 or IGFBP-3. These agonist variants are useful, for example, to improve the half-lives of IGF-I and insulin, respectively. |
| 02/05/2004 | US20040023859 New melanocortin receptor ligands are cyclic peptide analogs that preferably exhibit selectivity for the MC-4 and/or the MC-3 receptors relative to the other melanocortin receptors |
| 02/05/2004 | US20040023854 Adiponectin and uses thereof |
| 02/05/2004 | US20040022781 Proteins and nucleic acids encoding same |
| 02/05/2004 | US20040022777 Fragments and antagonists of heat shock protein 60 |
| 02/05/2004 | CA2494358A1 Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage |
| 02/05/2004 | CA2494069A1 Pellicle-resistant gelatin capsule |
| 02/05/2004 | CA2493980A1 Gelatin capsule exhibiting reduced cross-linking |
| 02/05/2004 | CA2493751A1 Novel arylimidazole derivatives, preparation and therapeutic uses thereof |
| 02/05/2004 | CA2492210A1 Aryl substituted hydantoin compounds and their use as sodium channel blockers |
| 02/05/2004 | CA2489165A1 Diazabicyclononane and -decane derivatives and their use as opioid receptor ligands |
| 02/04/2004 | EP1386932A1 Improved humanized immunoglobulins |
| 02/04/2004 | EP1386613A1 Compositions for preparing external carbon dioxide agents |
| 02/04/2004 | EP1386166A2 Anti-epileptogenic agents |
| 02/04/2004 | EP1385977A2 Secreted proteins |
| 02/04/2004 | EP1385937A1 Delivery of polynucleotide agents to the central nervous sysstem |
| 02/04/2004 | EP1385883A2 Transmembrane proteins |
| 02/04/2004 | EP1385878A2 Compounds that affect cd83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds |
| 02/04/2004 | EP1385874A1 Alpha conotoxin peptides with analgesic properties |
| 02/04/2004 | EP1385841A1 Sulfonamides |
| 02/04/2004 | EP1385840A1 Sulfonamides |
| 02/04/2004 | EP1385839A1 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 02/04/2004 | EP1385825A1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives |
| 02/04/2004 | EP1385550A2 Therapeutic method for inducing tolerance |
| 02/04/2004 | EP1385538A2 Chimeric vaccines |
| 02/04/2004 | EP1385518A1 Benzimidazolone compounds |
| 02/04/2004 | EP1385516A1 The treatment of scarring and related conditions using ppar-gamma activators |
| 02/04/2004 | EP1385514A1 Spiroindene and spiroindane compounds |
| 02/04/2004 | EP1385507A1 Sulfonamides |
| 02/04/2004 | EP1385500A1 Fatty alcohols and fatty acid esters useful for treatment of inflammation |
| 02/04/2004 | EP1385493A1 Substituted cyclohexan-1,4-diamine derivatives with constipating and peripheral analgesic properties |
| 02/04/2004 | EP1385476A2 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions |
| 02/04/2004 | EP1185291B1 Therapeutic agent comprising a botulinum neurotoxin |
| 02/04/2004 | CN1473144A Solid compositions suitable for oral administration containing non-hydroscopic salts of L-carnitine and alkanoyl L-carnitines with taurine chloride and glycine chloride |
| 02/04/2004 | CN1473047A Method for treating hypogonadism |
| 02/04/2004 | CN1137088C Solid compositions suitable for oral administration comprising L-carnitine or alkanoyl-L-carnitine magnesium fumarate |
| 02/03/2004 | US6686388 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 02/03/2004 | US6686335 Hydroxamate-containing cysteine and serine protease inhibitors |
| 02/03/2004 | US6686148 Methods for targeting RNA molecules |
| 02/03/2004 | CA2355987C Bicyclic amide derivatives and their use as muscle relaxants |
| 01/29/2004 | WO2004009816A1 Methods of treating conditions associated with an edg-1 receptor |
| 01/29/2004 | WO2004009784A2 Novel inhibitors of kinases |
| 01/29/2004 | WO2004009601A1 Azaindole kinase inhibitors |
| 01/29/2004 | WO2004009586A1 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders |
| 01/29/2004 | WO2004009582A1 Substituted thiophene carboxamide compounds for the treatment of inflammation |
| 01/29/2004 | WO2004009579A1 Novel compounds |
| 01/29/2004 | WO2004009560A1 Novel bio-active molecules |
| 01/29/2004 | WO2004009528A1 2,4-dihydroxybenzoic acid derivatives |
| 01/29/2004 | WO2004009123A2 Gastrointestinal delivery of genetic material coupled to a transporting agent |
| 01/29/2004 | WO2004008887A1 Fruit and/or vegetable derived composition |
| 01/29/2004 | WO2003049705A3 Use of pramipexole to treat amyotrophic lateral sclerosis |
| 01/29/2004 | WO2003020324A3 Methods for sterilizing preparations of digestive enzymes |
| 01/29/2004 | WO2002068652A3 Nov-x proteins and nucleic acids encoding same |
| 01/29/2004 | US20040019207 Amines such as 8-Benzyl-3-(3-pyridyl)-8-azabicyclo(3.2.1) oct-2-ene, that bind to nicotinic acetocholine receptors, used for prophylaxis of nervous system disorders, as analgesis, antiinflammatory agents and drug abuse |
| 01/29/2004 | US20040019084 Nitric oxide synthase inhibitors; antioxidant regenerants |
| 01/29/2004 | US20040019063 Nitrogen compounds such as 4-(7-Hydroxy-1,3-dioxo-tetrahydro-pyrrolo(1,2-c)imidazol-2-yl)-5,6,7,8-tetrahydronaphthalene-1-carbonitrile, used for prophylaxis of muscular disorders; aging |
| 01/29/2004 | US20040019052 5-(2,3-Difluorophenyl)-1H-pyrazolo(3,4-c)pyridazin-3-ylamine, e.g.; an enzyme inhibitor of GSK-3, a serine/threonine protein kinase; neuroprotectants in treatment of acute stroke, neurotraumatic injuries and diabetic conditions |
| 01/29/2004 | US20040018972 Autoimmune diseases; antiallergens; rheumatic diseases; antiinflammatory agents |
| 01/29/2004 | US20040018508 Surrogate antibodies and methods of preparation and use thereof |
| 01/29/2004 | US20040018251 Petasite extract is recovered from plant of the genus Petasites; effective in treating gastrointestinal diseases, asthmas, pollinosis, dysmenorrhea, eczemas, migraines, psoriasis and high blood pressure |
| 01/29/2004 | US20040018191 Neutralizing human anti-IGFR antibody |
| 01/29/2004 | CA2493774A1 2,4-dihydroxybenzoic acid derivatives |
| 01/29/2004 | CA2492922A1 Substituted thiophene carboxamide compounds for the treatment of inflammation |
| 01/29/2004 | CA2492862A1 Gastrointestinal delivery of genetic material coupled to a transporting agent |
| 01/29/2004 | CA2492665A1 Azaindole kinase inhibitors |
| 01/29/2004 | CA2466288A1 Methods of treating conditions associated with an edg-1 receptor |
| 01/28/2004 | EP1383895A2 Polynucleotides and polypeptides of the ifnalpha-5 gene |
| 01/28/2004 | EP1383892A2 Human extracellular matrix and cell adhesion polypeptides |
| 01/28/2004 | EP1383869A1 Progenitor cell populations, expansion thereof, and growth of non-hematopoietic cell types and tissues therefrom |
| 01/28/2004 | EP1383798A2 Transporters and ion channels |
| 01/28/2004 | EP1383789A2 Proteins associated with cell growth, differentiation, and death |
| 01/28/2004 | EP1383787A2 Sapogenin derivatives, their synthesis and use |
| 01/28/2004 | EP1383774A2 Dihydroimidazo[4,5-e]indole and 7h-pyrrolo[3,2-f]quinoxaline derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands |
| 01/28/2004 | EP1383768A1 Imidazo-pyrimidine derivatives as ligands for gaba receptors |
| 01/28/2004 | EP1383762A1 Tetrahydropyridyl-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same |
| 01/28/2004 | EP1383752A2 Deuterated 3-piperidinopropiophenone and medicaments containing said compounds |
| 01/28/2004 | EP1383750A2 Urea derivatives as integrin alpha 4 antagonists |
| 01/28/2004 | EP1383748A2 Novel compounds and compositions as cathepsin inhibitors |
| 01/28/2004 | EP1383743A2 Dual inhibitors of pde 7 and pde 4 |
| 01/28/2004 | EP1383506A2 Fused heterocyclic inhibitors of phosphodiesterase (pde) 7 |
| 01/28/2004 | EP1383496A2 Treatment of fibromyalgia and related fatigue syndromes using pindolol |
| 01/28/2004 | EP1383489A1 Carbamate compounds for use in preventing or treating neurodegenerative disorders |
| 01/28/2004 | EP1383483A1 Controlled delivery of tetracycline compounds and tetracycline derivatives |
| 01/28/2004 | EP1143946B1 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis |
| 01/28/2004 | CN1471534A 桥(连)哌嗪衍生物 Bridge (even) piperazine derivatives |